Tomeki

Prescription drug diversion and counterfeiting

Prescription drug diversion and counterfeiting

hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first-[second] session.

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1986

Publisher

U.S. G.P.O.

Language

eng

Pages

-